{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:25:20Z","timestamp":1792794320548,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor plasticity, the capacity of malignant cells to undergo reversible phenotypic switching, is a fundamental driver of lineage diversion and therapeutic resistance. While the bacterial microbiome is a recognized modulator of the tumor microenvironment (TME), the non-bacterial oncobiome, comprising the mycobiome (fungi) and virome (viruses), represents a critical but under-explored frontier in cellular adaptability. This review synthesizes current evidence regarding the mechanistic contributions of fungal and viral constituents to tumor plasticity and characterizes the molecular cross-talk that facilitates host cell reprogramming. We conducted a structured narrative synthesis of literature indexed in PubMed, Scopus, and Web of Science (2020\u20132026), focusing on high-throughput studies such as ITS sequencing, metagenomics NGS (mNGS), and single-cell network analyses. We specifically evaluated evidence concerning the activation of host pattern recognition receptors and the subsequent transcriptional rewiring of lineage-defining markers. Emerging data indicate that fungal dysbiosis, particularly involving Candida and Malassezia species, triggers the Dectin-1\/STAT3 signaling axis, a known inducer of epithelial-mesenchymal transition (EMT). Concurrently, the virome, ranging from integrated oncoviruses to reactivated endogenous retroviruses (ERVs), is shown to hijack the Wnt\/ \u03b2-catenin pathway, enforcing a progenitor-like stemness state. This inter-kingdom synergy promotes an immune-excluded niche, effectively shielding plastic sub-populations from cytotoxic stress and targeted therapies. The non-bacterial oncobiome provides genomic momentum and inflammatory cues necessary to lower the threshold for phenotypic switching. This review highlights that stabilizing the TME ecosystem through ecologically targeted therapy may be a prerequisite for overcoming drug resistance and improving clinical outcomes in refractory cancers.<\/jats:p>","DOI":"10.1186\/s43046-026-00370-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:28:32Z","timestamp":1779985712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The non-bacterial oncobiome: the role of the mycobiome and virome in tumor plasticity"],"prefix":"10.1186","volume":"38","author":[{"given":"Isaac Johnson","family":"Ajeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozhe Sunday Isaac","family":"Ikukpla\u2019si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"777","key":"370_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574(777):264\u20137. https:\/\/doi.org\/10.1038\/s41586-019-1608-2.","journal-title":"Nature"},{"issue":"20","key":"370_CR2","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, et al. A pan-cancer mycobiome analysis reveals fungal involvement in tumor biology. Cell. 2022;185(20):3807\u201322. https:\/\/doi.org\/10.1016\/j.cell.2022.09.005.","journal-title":"Cell"},{"issue":"50","key":"370_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01334-6","volume":"8","author":"Z Zong","year":"2023","unstructured":"Zong Z, Zhou F, Zhang L. The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal Transduct Target Therapy. 2023;8(50):1\u20133. https:\/\/doi.org\/10.1038\/s41392-023-01334-6.","journal-title":"Signal Transduct Target Therapy"},{"key":"370_CR4","doi-asserted-by":"publisher","first-page":"0931","DOI":"10.34133\/research.0931","volume":"8","author":"W Liu","year":"2025","unstructured":"Liu W, Zhu K, Wang L, Liu NN, Mao W. Unraveling the fungi-cancer connection. Research. 2025;8:0931. https:\/\/doi.org\/10.34133\/research.0931.","journal-title":"Research"},{"issue":"1","key":"370_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-025-02227-8","volume":"24","author":"T Ding","year":"2025","unstructured":"Ding T, Liu C, Li Z. The mycobiome in human cancer: Analytical challenges, molecular mechanisms, and therapeutic implications. Mol Cancer. 2025;24(1):18. https:\/\/doi.org\/10.1186\/s12943-025-02227-8.","journal-title":"Mol Cancer"},{"issue":"5","key":"370_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.trecan.2024.02.009","volume":"10","author":"W Liu","year":"2024","unstructured":"Liu W, Pi Z, Liu N, Mao W. Into the era of mycobiome-driven cancer research. Trends Cancer. 2024;10(5):389\u201392. https:\/\/doi.org\/10.1016\/j.trecan.2024.02.009.","journal-title":"Trends Cancer"},{"key":"370_CR7","doi-asserted-by":"publisher","unstructured":"He C, Chen J, Tian R, Zeng X, Han Q, Jiang C, Zou J, Yu T. Fungal Colonization by Malassezia globosa Promotes Breast Cancer Progression and M2 Macrophage Polarization Through the MBL-C3a-C3aR Signaling Pathway. Microbiologyopen 14(6):e70193 https:\/\/doi.org\/10.1002\/mbo3.701934","DOI":"10.1002\/mbo3.701934"},{"issue":"1","key":"370_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/microorganisms14010075","volume":"14","author":"J Wang","year":"2026","unstructured":"Wang J, Xu D, Hu S, Zheng B, Chen Y, Pan T. The impact of microbiome on breast cancer and regulatory strategies. Microorganisms. 2026;14(1):75. https:\/\/doi.org\/10.3390\/microorganisms14010075.","journal-title":"Microorganisms"},{"key":"370_CR9","doi-asserted-by":"publisher","first-page":"1596688","DOI":"10.3389\/fcimb.2025.1596688","volume":"15","author":"W Zhang","year":"2025","unstructured":"Zhang W, Zhang H, Gao Y, Lei J, Suo C. Fungi and cancer: Unveiling the complex role of fungal infections in tumor biology and therapeutic resistance. Front Cell Infect Microbiol. 2025;15:1596688. https:\/\/doi.org\/10.3389\/fcimb.2025.1596688.","journal-title":"Front Cell Infect Microbiol"},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.crmicr.2021.100090","volume":"3","author":"MAL Huet","year":"2022","unstructured":"Huet MAL, Lee CZ, Rahman S. A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci. 2022;3:100090. https:\/\/doi.org\/10.1016\/j.crmicr.2021.100090.","journal-title":"Curr Res Microb Sci"},{"key":"370_CR11","doi-asserted-by":"publisher","unstructured":"Pratt HG, Steinberger KJ, Mihalik NE, Ott S, Whalley T, Szomolay B et al. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Cancers (Basel). 14(1):194. https:\/\/doi.org\/10.3390\/cancers14010194","DOI":"10.3390\/cancers14010194"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41392-025-02499-y","volume":"11","author":"E Rozengurt","year":"2026","unstructured":"Rozengurt E, Eibl G. Pancreatic cancer:molecular pathogenesis and emerging therapeutic strategies. Sig Transduct Target Ther. 2026;11:6. https:\/\/doi.org\/10.1038\/s41392-025-02499-y.","journal-title":"Sig Transduct Target Ther"},{"issue":"20","key":"370_CR13","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and associations. Cell. 2022;185(20):3789\u2013806. https:\/\/doi.org\/10.1016\/j.cell.2022.09.005.","journal-title":"Cell"},{"issue":"4","key":"370_CR14","doi-asserted-by":"publisher","first-page":"104182","DOI":"10.5306\/wjco.v16.i4.104182","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhao R, Wang D, Sapudin SNM, Yahaya BH, Harun MSR, et al. Candida Albicans and colorectal cancer: a paradoxical role revealed through metabolite profiling and prognostic modelling. World J Clin Oncol. 2025;16(4):104182. https:\/\/doi.org\/10.5306\/wjco.v16.i4.104182.","journal-title":"World J Clin Oncol"},{"issue":"6","key":"370_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12032-025-02761-x","volume":"42","author":"NS Kiran","year":"2025","unstructured":"Kiran NS, Chatterjee A, Yashaswini C, Deshmukh R, Alsaidan OA, Bhattacharya S, et al. The gastrointestinal mycobiome in inflammation and cancer: unravelling fungal dysbiosis, pathogenesis, and therapeutic potential. Med Oncol. 2025;42(6):195. https:\/\/doi.org\/10.1007\/s12032-025-02761-x.","journal-title":"Med Oncol"},{"key":"370_CR16","doi-asserted-by":"publisher","unstructured":"Luan C, Xie L, Yang X et al. Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep 5:7980. https:\/\/doi.org\/10.1038\/srep07980","DOI":"10.1038\/srep07980"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3389\/fmicb.2018.01448","volume":"9","author":"E Balestrieri","year":"2018","unstructured":"Balestrieri E, Argaw-Denboba A, Gambacurta A, Cipriani C, Bei R, Serafino A, et al. Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: a new perspective for combination therapy. Front Microbiol. 2018;9:1448. https:\/\/doi.org\/10.3389\/fmicb.2018.01448.","journal-title":"Front Microbiol"},{"issue":"6","key":"370_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41588-023-01319-9","volume":"55","author":"B Rodriguez-Martin","year":"2023","unstructured":"Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2023;55(6):1080. https:\/\/doi.org\/10.1038\/s41588-023-01319-9.","journal-title":"Nat Genet"},{"issue":"3","key":"370_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0558-9.","journal-title":"Nat Genet"},{"issue":"3","key":"370_CR20","doi-asserted-by":"publisher","first-page":"e14086","DOI":"10.1016\/j.heliyon.2023.e14086","volume":"9","author":"T Rafael","year":"2023","unstructured":"Rafael T, Patricia G, Santiago C, Elis P, Viviana AR, Ana KZ. Human virome: implications in cancer. Heliyon. 2023;9(3):e14086. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14086.","journal-title":"Heliyon"},{"issue":"9","key":"370_CR21","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/cancers13091999","volume":"13","author":"A Petrizzo","year":"2021","unstructured":"Petrizzo A, Ragone C, Cavalluzo B, Mauriello A, Manolio C, Tagliamonte M, et al. Human endogenous retrovirus reactivation: implications for cancer immunotherapy. Cancers. 2021;13(9):1999. https:\/\/doi.org\/10.3390\/cancers13091999.","journal-title":"Cancers"},{"key":"370_CR22","doi-asserted-by":"publisher","unstructured":"Khanizadeh S, Hasanvand B, Lashgarian HE, Almasian M, Goudarzi G. Interaction of viral oncogenic proteins with the Wnt signalling pathway. Iran J Basic Med Sci 201; 21(7):651\u20139. https:\/\/doi.org\/10.2203\/IJBMS.2018.28903.6982","DOI":"10.2203\/IJBMS.2018.28903.6982"},{"key":"370_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/jj.molmed.2026.02.001","author":"KM Vivek","year":"2026","unstructured":"Vivek KM, Jamie LI, Hang C, Adam A, Jian-Hua M. Phage therapy in oncology: opportunities in cancer prevention and treatment. Trends Mol Med. 2026. https:\/\/doi.org\/10.1016\/jj.molmed.2026.02.001.","journal-title":"Trends Mol Med"},{"issue":"8","key":"370_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-02251","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies A, Zoubeidi A, Beltran H, Selth LA. The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov. 2023;13(8):1771\u201388. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-02251.","journal-title":"Cancer Discov"},{"issue":"12","key":"370_CR25","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/microorganisms9122538","volume":"9","author":"F Broecker","year":"2021","unstructured":"Broecker F, Moelling K. The roles of virome in cancer. Microorganisms. 2021;9(12):2538. https:\/\/doi.org\/10.3390\/microorganisms9122538.","journal-title":"Microorganisms"},{"issue":"8","key":"370_CR26","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3390\/ijms20081811","volume":"20","author":"AV Nguyen","year":"2019","unstructured":"Nguyen AV, Soulika AM. The Dynamics of the Skin\u2019s Immune System. Int J Mol Sci. 2019;20(8):1811. https:\/\/doi.org\/10.3390\/ijms20081811.","journal-title":"Int J Mol Sci"},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12935-025-03787","volume":"28","author":"YK Adlakha","year":"2025","unstructured":"Adlakha YK, Chihabra R. The human microbiome: redefining cancer pathogenesis and therapy. Cancer Cell Int. 2025;28:165. https:\/\/doi.org\/10.1186\/s12935-025-03787.","journal-title":"Cancer Cell Int"},{"key":"370_CR28","doi-asserted-by":"publisher","unstructured":"Mehra Y, Chalif J, Chambers L. The microbiome and ovarian cancer: insights, implications, and therapeutic opportunities. J Cancer Metastasis Treat. 2023;9(38). https:\/\/doi.org\/10.20517\/2394-4722.2023.107.","DOI":"10.20517\/2394-4722.2023.107"},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.20517\/cdr.2024.107","volume":"7","author":"L Zheng","year":"2024","unstructured":"Zheng L, Chang R, Liang B, Wang Y, Zhu Y, Jia Z, et al. Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment. Cancer Drug Resist. 2024;7:50. https:\/\/doi.org\/10.20517\/cdr.2024.107.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"370_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.20517\/mrr.2024.46","volume":"4","author":"C Cuinat","year":"2025","unstructured":"Cuinat C, Pan J, Comelli EM. Host-dependent alteration of the gut microbiota: the role of luminal microRNAs. Microbiome Res Rep. 2025;4(1):15. https:\/\/doi.org\/10.20517\/mrr.2024.46.","journal-title":"Microbiome Res Rep"},{"issue":"4","key":"370_CR31","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.xcrm.2024.101499","volume":"5","author":"H Cheng","year":"2024","unstructured":"Cheng H, Ma Y, Xu J, Wang W, Lu H, Quan C, et al. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Rep Med. 2024;5(4):101499. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101499.","journal-title":"Cell Rep Med"},{"issue":"7852","key":"370_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora S, Nagler A, Nejman D, Alon M, Barbolin C, Barnea E, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592(7852):138\u201343. https:\/\/doi.org\/10.1038\/s41586-021-03368-8.","journal-title":"Nature"},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12967-024-05709-3","volume":"22","author":"C Liu","year":"2024","unstructured":"Liu C, Fu L, Wang Y, Yang W. Influence of the gut microbiota on immune cell interactions and cancer treatment. J Trans Med. 2024;22:939. https:\/\/doi.org\/10.1186\/s12967-024-05709-3.","journal-title":"J Trans Med"},{"key":"370_CR34","doi-asserted-by":"publisher","unstructured":"Choudhry H. The microbiome and its implications in cancer immunotherapy. Molecules. 26(1):206. https:\/\/doi.org\/10.3390\/molecules26010206","DOI":"10.3390\/molecules26010206"},{"key":"370_CR35","doi-asserted-by":"publisher","unstructured":"Isenring J, Bircher L, Geirnaert A, Lacroix C. In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls. Microbiome Res Rep 2(1):2. https:\/\/doi.org\/10.20517\/mrr.2022.15","DOI":"10.20517\/mrr.2022.15"},{"issue":"2","key":"370_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.20517\/mrr.2021.09","volume":"1","author":"K Linehan","year":"2022","unstructured":"Linehan K, Dempsey EM, Ryan CA, Ross RP, Stanton C. First encounters of the microbial kind: perinatal factors direct infant gut microbiome establishment. Microbiome Res Rep. 2022;1(2):10. https:\/\/doi.org\/10.20517\/mrr.2021.09.","journal-title":"Microbiome Res Rep"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00370-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:28:33Z","timestamp":1779985713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00370-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00370-x","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}